Global Over The Counter (OTC) Analgesics Market 2023-2027
The over the counter (OTC) analgesics market is forecasted to grow by USD 6525.59 mn during 2022-2027, accelerating at a CAGR of 4.74% during the forecast period. The report on the over the counter (OTC) analgesics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing aging population globally, increasing prevalence of pain-related conditions, and growing number of mergers and acquisitions (M and A) activities.
Technavio's over the counter (OTC) analgesics market is segmented as below:
By Distribution Channel
By Geographical Landscape
- North America
- Rest of World (ROW)
This study identifies the growing number of launches of OTC analgesics as one of the prime reasons driving the over the counter (OTC) analgesics market growth during the next few years. Also, rising self-medication and awareness among consumers regarding OTC drugs and growing presence of e-pharmacy will lead to sizable demand in the market.
The report on the over the counter (OTC) analgesics market covers the following areas:
- Over the counter (OTC) analgesics market sizing
- Over the counter (OTC) analgesics market forecast
- Over the counter (OTC) analgesics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading over the counter (OTC) analgesics market vendors that include AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Cardinal Health Inc., Cipla Ltd., CV Sciences Inc., Endo International Plc, GlaxoSmithKline Plc, Medterra CBD, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc, Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Weefsel Pharma, and AKUMS. Also, the over the counter (OTC) analgesics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.